Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 29 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10982221

    Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  2. US 10982068

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  3. US 10975142

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  4. US 10973764

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  5. US 10975167

    Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  6. US 10975059

    Small molecule BRD4 modulators for HIV epigenetic regulation

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  7. US 10975124

    Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

    The Board of Regents of the University of Oklahoma · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  8. US 10966950

    Use of an RXR agonist in treating HER2+ cancers

    The Board of Regents of the University of Texas System · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  9. US 10967065

    Compounds for treating biofilm infection

    The Board of Regents of the University of Texas System · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  10. US 10959952

    Use of exosomes for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  11. US 10960029

    Devices and methods for umbilical cord processing

    The Board of Regents of the University of Texas System · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  12. US 10953031

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  13. US 10954217

    Sigma receptor binders

    The Board of Regents of the University of Texas System · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  14. US 10954192

    Pyrrolomycins and methods of using the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  15. US 10953113

    Imaging agents and methods of use

    The Board of Regents of the University of Oklahoma · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  16. US 10953110

    Dual emissive metal nanoparticles as ratiometric pH indicators

    The Board of Regents of the University of Texas System · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  17. US 10953209

    Treating tumors using TTFields combined with a PARP inhibitor

    The Board of Regents of the University of Texas System · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  18. US 10953040

    Methods of treating bacterial infections with penam β-lactam antibiotics and branched poly(ethylenimine)

    The Board of Regents of the University of Oklahoma · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  19. US 10945996

    Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  20. US 10947206

    cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  21. US 10945962

    Controlled-release peptide compositions and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  22. US 10947198

    Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

    The Board of Regents for Oklahoma State University · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  23. US 10946096

    Nitrobenzaldehyde proton release for manipulation of cellular acidosis

    The Board of Regents of the University of Texas System · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  24. US 10933126

    Clostridium difficile immunogenic compositions and methods of use

    The Board of Regents of the University of Oklahoma · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.